Catalyst Wire Dossier Catalyst Wire Dossier

BIZENGRI

ZENOCUTUZUMAB · Merus US, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BIZENGRI, covering 2024-12-04 to 2025-01-31. Get the full timeline:

Most recent: FDA Approved: BIZENGRI — Supplemental Application (Merus US, Inc.)

See pricing